Q2 FY2026 EarningsQ2 FY2026 beat consensus across key top and bottom-line metrics, with revenue reaching $22.8M vs. $22.7M expected and GAAP EPS of -$0.18 vs. -$0.21 expected. Core RNS System revenue grew 21% YoY, prompting management to raise full-year 2026 revenue guidance to $99.5M-$101.5M. The bottom-line improvement was driven by disciplined OpEx management, particularly in G&A, while the company maintains clinical momentum for its IGE indication expansion.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: NeuroPace(NPCE) the Revenue is 22.83 M (-2.95%), Beat estimate;the EBIT is -5.143 M (+24.63%), Beat estimate;the EPS is -0.18 (+30.77%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.02B2.95%
0.02B3.67%
+0.00B0.72%
EBITExceed expectations
-0.01B24.63%
-0.01B15.42%
+0.00B9.21%
EPSExceed expectations
-0.1830.77%
-0.207220.30%
+0.027210.47%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf